TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 242 filers reported holding TG THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,271,882 | -63.8% | 152,139 | +7.5% | 0.02% | -64.3% |
| Q2 2023 | $3,514,860 | -88.4% | 141,500 | -94.5% | 0.04% | -89.7% |
| Q4 2022 | $30,309,643 | +447.9% | 2,562,100 | +174.2% | 0.41% | +427.3% |
| Q3 2022 | $5,532,000 | +55.4% | 934,436 | +773.9% | 0.08% | +32.8% |
| Q3 2021 | $3,559,000 | -10.0% | 106,932 | +4.9% | 0.06% | -21.6% |
| Q2 2021 | $3,956,000 | -91.1% | 101,980 | -89.0% | 0.07% | -92.5% |
| Q1 2021 | $44,670,000 | +2482.1% | 926,766 | +2687.1% | 0.99% | +2054.3% |
| Q4 2020 | $1,730,000 | -67.7% | 33,252 | -83.4% | 0.05% | -73.7% |
| Q3 2020 | $5,349,000 | -17.5% | 199,875 | -39.9% | 0.18% | -31.9% |
| Q2 2020 | $6,480,000 | – | 332,652 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |